From WisPolitics.com/WisBusiness.com …
— Lawmakers last week circulated legislation that would allow people to sue if they were harmed by a gender transition procedure or treatment performed on them as a minor.
Sen. Rob Hutton, R-Brookfield, and Rep. Amanda Nedweski, R-Pleasant Prairie, recently sent a cosponsorship memo to other lawmakers seeking support for the proposal. They warn that long-term consequences of medical interventions covered by the bill are still unknown.
“Research has shown that puberty blockers can cause reduced bone density, and hormone therapy can lead to blood clots, stroke, cardiovascular disease and impaired fertility,” they wrote in the memo. “Concerns about cognitive development, insulin sensitivity, liver function and other sexual functions are also still being studied.”
They argue gender transition procedures and treatments are being used to treat “potentially transient mental health conditions,” noting the bill allows those affected to sue until they’re age 33.
The memo also references the American Medical Association’s guidance on needing comprehensive evaluations by medical professionals before moving ahead with “irreversible gender-affirming decisions” for minors.
It notes the legislation provides a “legal safe harbor” if providers can show they did their due diligence before recommending such interventions. The bill also has exceptions for situations where interventions are medically necessary, per the memo.
“This bill ensures that children who are administered gender transition drugs or surgeries and suffer harm as a result can also seek compensation,” bill authors wrote.
The cosponsorship deadline is 5 p.m. Aug. 4.
See the memo.
Top Stories
– 3 Democrat-led states have rolled back Medicaid access for people lacking permanent legal status
– Over half of Americans say ‘big, beautiful bill’ going to raise health care costs: Poll
– FDA appoints George Tidmarsh as top drug regulator
– Republicans are ready to revive stalled health care legislation. Dems want the GOP to pay a price.
– A creek with atomic waste from WWII is linked to increased cancer risk
– Sarepta says it won’t comply with FDA request to stop shipping gene therapy Elevidys
Press Releases
